Retinal thickness and microvascular alterations observed by optical coherence tomography in antineutrophil cytoplasmic antibody-associated vasculitis: a cross-sectional study

被引:0
|
作者
Li, Zi-Yuan [1 ]
Kang, Min [1 ]
Qian, Xian-Zhe [2 ]
Peng, Rui [1 ]
Hong, Qi [1 ]
Ying, Ping [1 ]
Huang, Hui [1 ]
Wang, Xiao-Yu [1 ]
Zeng, Yan-Mei [1 ]
Hu, Jin-Yu [1 ]
Chen, Xu [3 ]
Wu, Rui [2 ]
Shao, Yi [1 ]
Yu, Shu-Jiao [1 ,2 ]
机构
[1] Nanchang Univ, Jiangxi Med Coll, Affiliated Hosp 1, Dept Ophthalmol, 17 Yongwaizheng St, Nanchang 330006, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 1, Jiangxi Med Coll, Dept Rheumatol, Nanchang, Peoples R China
[3] Maastricht Univ, Ophthalmol Ctr, Maastricht, Netherlands
基金
中国国家自然科学基金;
关键词
Antineutrophil cytoplasmic antibody-associated vasculitis (ANCA-AAV); optical coherence tomography angiography (OCTA); retinal thickness (RT); superficial vascular density (SVD); RHEUMATOLOGY CLASSIFICATION CRITERIA; 2022; AMERICAN-COLLEGE; OCULAR MANIFESTATIONS; FLUORESCEIN ANGIOGRAPHY; DIABETIC-RETINOPATHY; GRANULOMATOSIS; ALLIANCE; DENSITY; OCT;
D O I
10.21037/qims-23-1717
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: As an autoimmune disease, antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) often affects multiple organs, including the ocular system. This study aims to investigate differences in retinal thickness (RT) and retinal superficial vascular density (SVD) between patients with AAV and healthy controls (HCs) using optical coherence tomography angiography (OCTA). Currently, these differences are not clear. Methods: A total of 16 AAV individuals (32 eyes) and 16 HCs (32 eyes) were recruited to this crosssectional study conducted in the First Affiliated Hospital of Nanchang University from June 2023 to September 2023. The study protocol conformed with the tenets of the Declaration of Helsinki (as revised in 2013). Each image observed by OCTA was divided into 9 regions using the Early Treatment Diabetic Retinopathy Study (ETDRS) subzones as a guide. Results: In the full layer, the RT of AAV patients was found to be significantly reduced in the inner superior (IS, P<0.001), outer superior (OS, P=0.003), inner temporal (IT, P=0.003), and outer temporal (OT, P<0.001) regions; inner RT was significantly lower in the IS (P=0.006), OS (P<0.001), inner nasal (IN, P=0.005), outer nasal (ON, P<0.001), and center (C, P=0.01) regions than that in HCs. Outer RT of AAV patients showed a reduction in the IS (P<0.001), as well as IT (P=0.008), and OT (P<0.001) regions. No statistically significant differences were seen in the different subregions in other different layers (P>0.05). Only the inner inferior (II) and outer inferior (OI) regions of SVD in AAV patients did not differ significantly from controls. All other regions showed a reduction in SVD. The details are as follows: IS (P<0.001), OS (P<0.001), IT (P=0.005), OT (P<0.001), IN (P<0.001), ON (P<0.001), and C (P=0.003). According to receiver operating characteristic (ROC) curve analysis, the full IS region [area under the curve (AUC): 0.8892, 95% confidence interval (CI): 0.8041-0.9742, P<0.001] had the highest diagnostic value for AAV-induced reduction in RT. The IS (AUC: 0.9121, 95% CI: 0.8322-0.9920, P<0.001) region was also the most sensitive to changes in SVD of AAV individuals. In addition, we found that SVD in the IN region (r=-0.4224, 95% CI: -0.6779 to -0.0757, P=0.02) as well as mean visual acuity (r=-0.3922, 95% CI: -0.6579 to -0.0397, P=0.03) of AAV patients were negatively correlated with disease duration. However, we did not find an association between SVD and RT in this study. Conclusions: The findings from OCTA indicated a reduction in RT and SVD among patients with AAV. OCTA allows for the evaluation of AAV-related ocular lesions and holds promise for monitoring of disease progression through regular evaluations.
引用
收藏
页码:4998 / 5011
页数:14
相关论文
共 50 条
  • [31] Risk factors for renal outcomes in children with antineutrophil cytoplasmic antibody-associated vasculitis: a nationwide retrospective study in China
    Tan, Li-Wen
    Wan, Jun-Li
    Zhu, Chun-Hua
    Xu, Hong
    Xia, Zheng-Kun
    Chen, Li-Zhi
    Wu, Xiao-Chuan
    Wang, Fang
    Liu, Xiao-Rong
    Zhao, Cheng-Guang
    Li, Xiao-Zhong
    Mao, Jian-Hua
    Wang, Xiao-Wen
    Huang, Wen-Yan
    Li, Yu-Hong
    Zhang, Jian-Jiang
    Feng, Shi-Pin
    Yang, Jun
    Liu, Jiao-Jiao
    Gao, Chun-Lin
    Rong, Li-Ping
    Shuai, Lan-Jun
    Xu, Ke
    Zhang, He-Jia
    Li, Qiu
    Zhang, Ai-Hua
    Wang, Mo
    WORLD JOURNAL OF PEDIATRICS, 2024, 20 (05) : 506 - 516
  • [32] Neutrophilic Dermatoses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis A French Multicenter Study of 17 Cases and Literature Review
    de Boysson, Hubert
    Silva, Nicolas Martin
    de Moreuil, Claire
    Neel, Antoine
    de Menthon, Mathilde
    Meyer, Olivier
    Launay, David
    Pagnoux, Christian
    Guillevin, Loic
    Puechal, Xavier
    Bienvenu, Boris
    Aouba, Achille
    MEDICINE, 2016, 95 (11)
  • [33] Intravenous Immunoglobulin in Antineutrophil Cytoplasmic Antibody-associated Vasculitis: Study of 28 Cases from a Single Univeristary Hospital
    Villanueva, Fabricio Benavides
    Corrales, Cristina
    Rio, Vanesa Calvo
    Loricera, Javier
    Aviles, Nuria
    Madrigal, Juan M. Blanco
    Castaneda, Santos
    Gay, Miguel Angel Gonzalez
    Blanco, Ricardo
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2146 - 2148
  • [34] LONG TERM OUTCOMES OF DIFFUSE ALVEOLAR HAEMORRHAGE IN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS: A SINGLE CENTRE STUDY
    Yadavalli, J. N. Durga R.
    Telang, Kaustubh
    Khatri, Prabin
    Dhuria, Shahzeene
    Ekbote, Gayatri
    Gupta, Rajiva
    RHEUMATOLOGY, 2024, 63 : I161 - I161
  • [35] HLA-DPB1 as a Risk Factor for Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis A Cohort Study
    Hilhorst, Marc
    Arndt, Fabian
    Kemna, Michael Joseph
    Wieczorek, Stefan
    Donner, Yoni
    Wilde, Benjamin
    Epplen, Joerg Thomas
    van Paassen, Pieter
    Tervaert, Jan Willem Cohen
    ARTHRITIS & RHEUMATOLOGY, 2016, 68 (07) : 1721 - 1730
  • [36] Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis (CYCLOPS study)
    Koetter, I.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2009, 68 (07): : 575 - 577
  • [37] Clinical profile and outcome of antineutrophil cytoplasmic antibody-associated vasculitis: A retrospective observational study from South India
    Santhanam, Sham
    Murugesan, Hema
    Mohanasundaram, Kavitha
    INDIAN JOURNAL OF RHEUMATOLOGY, 2022, 17 (03) : 255 - 263
  • [38] Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study
    Sada, Ken-ei
    Yamamura, Masahiro
    Harigai, Masayoshi
    Fujii, Takao
    Dobashi, Hiroaki
    Takasaki, Yoshinari
    Ito, Satoshi
    Yamada, Hidehiro
    Wada, Takashi
    Hirahashi, Junichi
    Arimura, Yoshihiro
    Makino, Hirofumi
    ARTHRITIS RESEARCH & THERAPY, 2014, 16 (02)
  • [39] Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and the Risk of Developing Incidental Tuberculosis: A Population-Based Cohort Study
    Chan, Shan-Ho
    Li, Ming-Feng
    Ou, Shih-Hsiang
    Lin, Mei-Chen
    Wang, Jen-Hung
    Lee, Po-Tsang
    Chen, Hsin-Yu
    MEDICINA-LITHUANIA, 2023, 59 (11):
  • [40] Acute coronary syndrome in antineutrophil cytoplasmic antibody-associated vasculitis: a Korean single-centre cohort study
    Kim, Jin Seok
    Park, Yong-Beom
    Lee, Sang-Won
    JOURNAL OF RHEUMATIC DISEASES, 2023, 30 (02): : 106 - 115